-
1
المؤلفون: Katsumi Kadekawa, Shizuo Yamada, Yoshihiko Ito, Saori Nishijima, Kimio Sugaya
المصدر: Pharmacology & Therapeutics. 189:130-148
مصطلحات موضوعية: medicine.medical_specialty, 030232 urology & nephrology, Urology, Muscarinic Antagonists, urologic and male genital diseases, 03 medical and health sciences, 0302 clinical medicine, Fesoterodine, medicine, Darifenacin, Animals, Humans, Pharmacology (medical), Oxybutynin, Pharmacology, Solifenacin, Antimuscarinic Agent, Urinary Bladder, Overactive, business.industry, Brain, medicine.disease, female genital diseases and pregnancy complications, Overactive bladder, 030220 oncology & carcinogenesis, Propiverine, Tolterodine, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76ff57c7ef5b5a493a6e2cb228497882Test
https://doi.org/10.1016/j.pharmthera.2018.04.010Test -
2
المؤلفون: Mohamed-Elmoctar Neine, Jameel Nazir, Isaac Odeyemi, Samuel Aballéa, K. Maman, Zalmai Hakimi, B. Briquet, Andy Garnham
المصدر: Value in Health. 18:783-790
مصطلحات موضوعية: Adult, Comparative Effectiveness Research, medicine.medical_specialty, Time Factors, Cost-Benefit Analysis, Urinary Bladder, Urology, Adrenergic beta-3 Receptor Agonists, Muscarinic Antagonists, Severity of Illness Index, Drug Costs, State Medicine, Decision Support Techniques, medicine, Fesoterodine, Darifenacin, Humans, Computer Simulation, Oxybutynin, Solifenacin, Urinary Bladder, Overactive, Trospium chloride, business.industry, Patient Selection, Health Policy, cost-effectiveness analysis, Public Health, Environmental and Occupational Health, Bayes Theorem, medicine.disease, Markov Chains, United Kingdom, mirabegron, Thiazoles, Models, Economic, Treatment Outcome, Overactive bladder, Anesthesia, Quality of Life, Health Resources, Acetanilides, antimuscarinic drugs, overactive bladder, Quality-Adjusted Life Years, Tolterodine, Mirabegron, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31e50b51cafe65742d60c731aea8282cTest
https://doi.org/10.1016/j.jval.2015.05.011Test -
3
المؤلفون: Otto Stroosma, Johan Vande Walle, David T Bolong, Piet Hoebeke, Ellen Dahler, Frank Verheggen, Israel Franco, Brigitte Bosman, Leon N. Davies, Malgorzata Baka-Ostrowska, Robert Snijder, Donald Newgreen
المصدر: Journal of Pediatric Urology. 16:180.e1-180.e8
مصطلحات موضوعية: Adult, medicine.medical_specialty, Constipation, Urology, 030232 urology & nephrology, Renal function, Muscarinic Antagonists, 03 medical and health sciences, 0302 clinical medicine, 030225 pediatrics, medicine, Humans, Prospective Studies, Urinary Bladder, Neurogenic, Child, Oxybutynin, Adverse effect, Neurogenic bladder dysfunction, Solifenacin, Urinary bladder, Urinary Bladder, Overactive, business.industry, Solifenacin Succinate, medicine.disease, Treatment Outcome, Urinary Incontinence, medicine.anatomical_structure, Tolerability, Pediatrics, Perinatology and Child Health, medicine.symptom, business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a79897b5213343a7d2242822501680bTest
https://doi.org/10.1016/j.jpurol.2019.12.012Test -
4
المؤلفون: Anju Goyal, Charlotte Melling
المصدر: Journal of Pediatric Urology. 16:37.e1-37.e8
مصطلحات موضوعية: medicine.medical_specialty, Urology, Pharmacological management, 030232 urology & nephrology, Botulinum toxin a, 03 medical and health sciences, 0302 clinical medicine, 030225 pediatrics, medicine, Humans, Prospective Studies, Practice Patterns, Physicians', Child, Oxybutynin, Solifenacin, Urinary Bladder, Overactive, business.industry, medicine.disease, United Kingdom, Overactive bladder, Health Care Surveys, Family medicine, Pediatrics, Perinatology and Child Health, Respondent, Tolterodine, Mirabegron, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c6d0b6408aa27b039b630ca36904623Test
https://doi.org/10.1016/j.jpurol.2019.10.013Test -
5
المؤلفون: Adrian Wagg, Mark Dale, Reiner Tretter, Gerhard Compion, Bridget Stow
المصدر: European Urology. 64:74-81
مصطلحات موضوعية: Male, Solifenacin Succinate, Aging, Quinuclidines, medicine.medical_specialty, Time Factors, Urology, Muscarinic Antagonists, Placebo, law.invention, Cognition, Double-Blind Method, Randomized controlled trial, Memory, Risk Factors, law, Tetrahydroisoquinolines, medicine, Humans, Attention, Cognitive Dysfunction, Least-Squares Analysis, Oxybutynin, Aged, Aged, 80 and over, Analysis of Variance, Cross-Over Studies, Solifenacin, Urinary Bladder, Overactive, business.industry, Age Factors, Crossover study, United Kingdom, Treatment Outcome, Tolerability, Physical therapy, Mandelic Acids, Urological Agents, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::092ddac39a58269b58cb565d37545e7dTest
https://doi.org/10.1016/j.eururo.2013.01.002Test -
6
المؤلفون: Roxana Geoffrion, Danny Lovatsis, Jens-Erik Walter, Queena Chou, William Easton, Annette Epp, Marie-Andrée Harvey, Annick Larochelle, Kenny Maslow, Grace Neustaedter, Dante Pascali, Marianne Pierce, Jane A. Schulz, Vyta Senikas, David Wilkie
المصدر: Journal of Obstetrics and Gynaecology Canada. 34:1092-1101
مصطلحات موضوعية: Canada, medicine.medical_specialty, medicine.drug_class, Drug Resistance, Cholinergic Antagonists, Vaginal estrogen, Transdermal estrogen, Internal medicine, medicine, Anticholinergic, Humans, Oxybutynin, Urinary bladder, Solifenacin, Urinary Bladder, Overactive, business.industry, Obstetrics and Gynecology, Estrogens, Urinary Incontinence, Urge, medicine.disease, medicine.anatomical_structure, Overactive bladder, Anesthesia, Female, Treatments for overactive bladder, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdbdf44bbcd01eab384b35e166e7f00dTest
https://doi.org/10.1016/s1701-2163Test(16)35440-8 -
7
المؤلفون: Silvia Secco, Stefano Cavalleri, Antonio Galfano, Vincenzo Ficarra, Carolina D'Elia, Giacomo Novara, Walter Artibani
المصدر: European Urology. 54:740-764
مصطلحات موضوعية: medicine.medical_specialty, Tolterodine Tartrate, Urology, Phenylpropanolamine, Muscarinic Antagonists, law.invention, detrusor overactivity, Trospium, Cresols, Randomized controlled trial, overactive bladder, Urgency frequency syndrome, Muscarinic receptor antagonist, Darifenacin, Emepronium, Fesoterodine, Oxybutynin, Propantheline, Propiverine, Solifenacin, Tolterodine, law, Internal medicine, medicine, Humans, Benzhydryl Compounds, Randomized Controlled Trials as Topic, Urinary Bladder, Overactive, business.industry, Trospium chloride, medicine.disease, Overactive bladder, Anesthesia, Mandelic Acids, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0a762d8e5d4aa1a652a2e4dbb607d09Test
https://doi.org/10.1016/j.eururo.2008.06.080Test -
8
المؤلفون: Nurum Erdem, Franklin Chu
المصدر: The American Journal of Medicine. 119:29-36
مصطلحات موضوعية: medicine.medical_specialty, Solifenacin, business.industry, Urge urinary incontinence, Urinary incontinence, General Medicine, medicine.disease, Cholinergic Antagonists, Surgery, Urinary Incontinence, Tolerability, Overactive bladder, Behavior Therapy, medicine, Darifenacin, Humans, Tolterodine, medicine.symptom, Intensive care medicine, Oxybutynin, business, Aged, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22ab56b5bda1e97e5b27b18f37d49489Test
https://doi.org/10.1016/j.amjmed.2005.12.014Test -
9
المؤلفون: Christopher R. Chapple, Julie Ann Dooley, Vik Khullar, Zahava Gabriel
المصدر: European Urology. 48:5-26
مصطلحات موضوعية: Clinical Trials as Topic, medicine.medical_specialty, Solifenacin, Antimuscarinic Agent, business.industry, Urology, Muscarinic Antagonists, medicine.disease, law.invention, Surgery, Treatment Outcome, Urinary Incontinence, Tolerability, Randomized controlled trial, Overactive bladder, law, Internal medicine, medicine, Humans, Tolterodine, Adverse effect, business, Oxybutynin, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7130a7aaa4b1fb3435a1ced14cd4d072Test
https://doi.org/10.1016/j.eururo.2005.02.024Test -
10
المؤلفون: Norman Zinner, Martin C. Michel, Matthias Oelke
المساهمون: Other Research, Pharmacology and pharmacotherapeutics, Cancer Center Amsterdam, Amsterdam Public Health, Urology
المصدر: Drug discovery today : Therapeutic strategies, 2(1), 1-6. Elsevier Limited
مصطلحات موضوعية: Pharmacology, medicine.medical_specialty, Solifenacin, Urge urinary incontinence, business.industry, Urology, medicine.disease, Tolerability, Overactive bladder, Drug Discovery, Muscarinic acetylcholine receptor, medicine, Darifenacin, Molecular Medicine, Tolterodine, Oxybutynin, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91197e687826f887102873d0339aa2ddTest
https://doi.org/10.1016/j.ddstr.2005.05.003Test